The 3,6-dideoxyhexoses, usually confined to the cell wall lipopolysaccharide of gram-negative bacteria, are essential to serological specificity and are formed via a complex biosynthetic pathway beginning with CDP-D-hexoses. In particular, the biosynthesis of CDP-ascarylose, one of the naturally occurring 3,6-dideoxyhexoses, consists of five enzymatic steps, with CDP-6-deoxy-A3'4-glucoseen reductase (E3) participating as the key enzyme in this catalysis. This enzyme has been previously purified from Yersinia pseudotberculosis by an unusual procedure (protocol I) including a trypsin digestion step (0. Han, V. P. Miller, and H.-W. Liu, J. Biol. Chem. 265:8033-8041, 1990). However, the cloned gene showed disparity with the expected gene characteristics, and upon expression, the resulting gene product exhibited no E3 activity. These findings strongly suggested that the protein isolated by protocol I may have been misidentified as E3. A reinvestigation of the purification protocol produced a new and improved procedure (protocol II) consisting of DEAESephacel, phenyl-Sepharose, Cibacron blue A, and Sephadex G-100 chromatography, which eliciently yielded a new homogeneous enzyme composed of a single polypeptide with a molecular weight of 39,000. This highly purified protein had a specific activity nearly 8,000-fold higher than that of cell lysates, and more importantly, the corresponding gene (ascD) was found to be part of the ascarylose biosynthetic cluster. Presented are the identification and confirmation of the E3 gene through cloning and overexpression and the culminating purification and unambiguous assignment of homogeneous E3. The nucleotide and translated amino acid sequences of the genuine E3 are also presented.
The deoxy sugars, long known as an important class of carbohydrate, are found ubiquitously in nature (7, 16, 47) . They are formally derived from common sugars by the displacement of one or more hydroxyl groups with hydrogens. Such a substitution generally induces a dramatic alteration of the biological role of the resulting sugar and is responsible for a fundamental change in the metabolism of the product. Particularly notable are the 3,6-dideoxyhexoses found in the lipopolysaccharides (LPS) of gram-negative bacteria (2) . Since LPS is the major surface antigen of the gram-negative cell envelope, this class of dideoxyhexose as the nonreducing end group of LPS has been identified as the key antigenic determinant. In addition, they have also been found to contribute to the serological specificity of many immunologically active polysaccharides (5, 24, 33, 46) . Inspired by their specific association with LPS and the intriguing nature of their immunological effects, substantial effort has been devoted to exploring their biosynthetic formation (10, 13) . However, although the nature of the precursors of these dideoxy sugars has been well defined and possible routes for their formation have been CDP-6-DEOXY-A3'4-GLUCOSEEN REDUCTASE over, both the 4R and 4S hydrogens of NADPH were found to be labile in this reduction step, making E3 the only enzyme that lacks prochiral recognition of the two diastereotopic methylene hydrogens on the coenzyme (35) . Since the net distance for an effective hydride transfer is approximately 0.55 A (0.055 nm) (14, 48) , for E3 to directly reduce the E1-bound intermediate 5, the active sites of these two enzymes must thus be brought into close proximity. This scenario, however, invokes a potentially substantial and unfavorable steric interference. It is also important to note that E3 is capable of oxidizing NAD(P)H in the presence of oxygen (12, 35) . However, unlike other known NAD(P)H oxidases, which are flavin dependent, the reported E3 does not contain any chromophoric group with an absorption above 300 nm. All of these unusual properties of E3 are not readily explicable and thus challenge our understanding of this important biological reduction.
In an effort to elucidate the mechanism by which the sugar deoxygenation and/or the coenzyme NADH oxidation are affected, we have purified an E3 equivalent (14, 15) , by monitoring its NADH:dichlorophenolindophenol (DCPIP) oxidoreductase activity, from Yersinia pseudotuberculosis. This enzyme showed no obvious absorption above 300 nm and contained no metal constituents, signifying again the absence of any common cofactors as reported earlier by GonzalezPorque and Strominger (12) . Since the oxygen metabolite was determined to be H202, the formation of which is stoichiometrically proportional to the amount of NADH consumed, this enzyme-catalyzed NADH oxidation is clearly an overall twoelectron redox process. Our studies also revealed O2-as the hypothetical reducing intermediate, suggesting that H202 formation is not a direct two-electron reduction of molecular oxygen but is instead a one-electron reduction followed by dismutation of the nascent superoxide. This finding of E3's two-electron/one-electron switching capability provides compelling evidence that it operates through a radical mechanism and also suggests the participation of an enzyme-bound organic cofactor which mediates the obligatory two-electron/oneelectron conversion. The mechanistic revision of the reduction step from a hydride transfer to an electron relay process not only explains the lack of direct hydride transfer from NAD(P)H in the reduction of the glucoseen-PMP complex 5 but also alleviates the spatial and steric constraints imposed on the delivery of reducing equivalents from E3 to El.
There is little doubt that further mechanistic studies of E3 require, foremost, the resolution of the structure and function of the putative organic coenzyme. Unfortunately, past attempts to isolate this cofactor were impeded by the limited availability of E3. In our recent effort to develop a large-scale purification scheme for E3, we were surprised to discover that the previously isolated E3 was a mixture of two proteins, with the desired enzyme being a minor component (27) . In this paper, we report molecular evidence supporting this unexpected finding, the isolation of the genuine E3 from Y. pseudotuberculosis, and the cloning, sequencing, and expression of the E3 (ii) Method 2. GC-MS assay. The Es product was generated by using an in vitro system similar to that described above for the TBA assay. After being quenched by NaBH4 (10 upmol, 30 min), the reduced sugar products were boiled for 10 min in the presence of HCl (pH 2.0), neutralized to pH 7.0 with NaOH, and lyophilized to dryness. The solid residue was redissolved in NH40H (0.5 M, 600 pl) and treated with a solution of NaBH4 in dimethyl sulfoxide (20 mg in 1 ml) at 40°C for 1.5 h, and the reaction was quenched with glacial acetic acid. Acetic anhydride (6 ml) and 1-methylimidazole (2.5 pumol) were added, and the resulting mixture was stirred for 1 h at room temperature. Routine workup followed by evaporation in vacuo gave a residue which was directly subjected to gas chromatographymass spectrometry (GC-MS) analysis (44) .
(iii) Method 3. NADHLDCPIP oxidoreductase activity. The NADH:DCPIP oxidoreductase activity of E3 was determined, as previously described (15) Growth of cells. An overnight culture of Y pseudotuberculosis was grown in tryptic soy broth medium (3%, 9 liters) in an incubator-shaker (Lab-Line) with vigorous agitation (140 rpm) at 28°C. This inoculum culture was then diluted 12-fold into a 110-liter fermentor (Stainless Steel Products) and grown at 28°C, 100 rpm, pH 7.5. The culture was harvested in the early to mid-logarithmic phase by centrifugation. A typical yield was 400 to 500 g (wet weight) of cells per 110 liters of culture. All cell culture and harvesting procedures were performed at the Biological Process Technology Institute, University of Minnesota.
Enzyme purification. All operations were carried out at 4°C. To preclude enzyme inhibition by exogenous trace metals during purification, all buffers contained 1 mM EDTA unless otherwise specified. The results of the purification are summarized in Table 1 . It should be noted that enzyme purified by this new protocol (protocol II) is different from the protein isolated by the old procedure (protocol I) which included a trypsin digestion step (15) .
(i) Step 1. Crude extracts. Cells from 110 liters of culture (520 g [wet weight]) were resuspended in four times their volume (2.1 liters) of 50 mM potassium phosphate buffer (pH 7.5), and then the protease inhibitor solution was added. The cells were disrupted by sonication for 2 min in batches of 200 ml, at 45-s intervals, with a VirSonic model 300 sonicator at 70% output. The temperature of the extracts was carefully controlled so as not to exceed 5°C during this process. Cellular debris was removed by centrifugation (4,420 x g, 20 min). The supernatant solution was diluted with the same buffer to 2.9 liters and was designated the crude extract.
(ii) Step 2. Streptomycin sulfate treatment. Streptomycin sulfate (5% aqueous solution, 550 ml) was added drop by drop to the crude extract to a final concentration of 0.8%. After standing for an additional hour with stirring, the precipitate was eliminated by centrifugation at 14,000 x g for 2 h. The supernatant solution (3.3 liters) was diluted with 1 M potassium phosphate buffer (pH 7.5, 330 ml) and carried on to the next step.
(iii) Step 3. Ammonium sulfate precipitation. Solid ammonium sulfate was slowly added to the protein solution from step 2 to give a final concentration of 65% saturation. After addition was complete, the cloudy solution was stirred for another 10 h. The precipitated proteins were collected by centrifugation (4,400 x g, 20. min) and were redissolved in a minimum amount of 50 mM potassium phosphate buffer (pH 7.5) . This solution was dialyzed against 40 liters of the same buffer for 24 h with four changes of buffer.
(iv)
Step 4. DEAE-Sephacel column chromatography. The solution from step 3 (1 liter) was applied to a column of DEAE-Sephacel (4.5 by 40 cm) equilibrated with 50 mM potassium phosphate buffer (pH 7.5). The column was washed with the same buffer (1 liter) and then eluted with a linear gradient of potassium phosphate (50 to 200 mM, pH 7.5, 5-liter total). Fractions of 16 ml were collected throughout. The contents of fractions 105 to 125 were pooled and concentrated to 32 ml via an Amicon ultrafiltration unit (PM-30 membrane).
(v)
Step 5. Phenyl-Sepharose column chromatography. The enzyme solution from step 4 was adjusted to 0.9 M KCI by the addition of 2.5 M KC1 in 50 mM potassium phosphate buffer (18 ml). This solution was then applied to a phenyl-Sepharose column (2.5 by 45 cm) which was preequilibrated with KCl (0.9 M) in potassium phosphate buffer (50 mM, pH 7.5). The column was washed with 0.9 M KCl buffer (90 ml) and then eluted with a linear gradient of 0.9 to 0 M KCl (500 ml) in the same phosphate buffer. Fractions of 6 ml were collected. The contents of fractions 72 to 88 were pooled and concentrated (YM-10 membrane).
(vi) Step 6. Blue A column chromatography. The material from step 5 was loaded onto a column of blue A (2 by 10 cm) and incubated for 45 min. Elution was then started with a linear gradient between 0 and 0.7 M KCl in 50 mM potassium phosphate buffer (140 ml each). Fractions of 2 ml were collected throughout. Active fractions (fractions 38 to 44) were combined and concentrated to 1.6 ml (YM-10 membrane).
(vii)
Step 7. Sephadex G-100 column chromatography. The enzyme solution from step 6 was chromatographed on a column (1.5 by 170 cm) of Sephadex G-100 equilibrated with 50 mM potassium phosphate buffer (pH 7.5). The column was then washed with the same buffer. Fractions of 3 ml were collected, and the desired protein was found in fractions 38 to 46. The active fractions were combined, concentrated (YM-10 membrane), and stored at -85°C.
SDS-PAGE. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was used to monitor purification of E3 and estimate the relative molecular mass of the protein. Electrophoresis was carried out at room temperature at a constant 120 V (-30 mA) with a 6% stacking gel and 13% resolving gel in the discontinuous buffer system of Laemmli (21) . Prior to electrophoresis, the samples were incubated at 100°C for 10 min in a solution containing 0.5% SDS and 5% 2-mercaptoethanol. Gels were stained with the preparation of Vesterberg (41) and destained with acetic acid-ethanol-water (15:20: 165 by volume).
Molecular weight determination. The subunit molecular weight was determined by SDS-PAGE as described by Laemmli (21) . The molecular weight of the native enzyme was determined by gel filtration performed on a column of Sephadex G-100 (1.5 by 170 cm). The column was calibrated by separate chromatographic runs with protein standards. The molecular weight of the purified protein was estimated by the method of Andrews (1) .
Amino-terminal analysis. The N-terminal sequence was determined by an Applied Biosystem 470A protein sequencer with an on-line 120A HPLC system. Analyses were carried out at the Microchemical Facility in the Institute of Human Genetics of the University of Minnesota, and the results were confirmed by Theodore Thannhauser at the Baker Laboratory of Chemistry, Cornell University.
Isoelectric focusing. The isoelectric pH of E3 was determined by a Pharmacia Phast-System instrument. A preformed PhastGel IEF 3-9 plate was used as specified by the manufacturer. The protein bands were visualized by silver staining (30) .
Oligonucleotide probes. The mixed oligonucleotide probes used in the hybridization, SFL2 and SFL4, were designed on the basis of the respective amino acid sequence near the amino terminus of each protein purified by either the old method (protocol I [15] derived from Eod (27, 40) .
Analogously, the subgenomic library YPT2 was constructed by size selection of 15-to 23-kb fragments of BamHI-digested genomic DNA of Y pseudotuberculosis, which was identified by Southern hybridization with the mixed probe SFL2. The subsequent ligation with commercially digested BamHI X EMBL3 arms (1 ,ug) and packaging by using Gigapack II Plus packaging mix were done as instructed by the manufacturer. The resulting plaques were bound to Duralose membranes and screened by using the SFL2 probe. The isolated recombinant was then replated, rescreened, and labeled pYPT2.
Restriction analysis and plasmid construction. Restriction mapping of the cloned DNA Nucleotide sequence accession number. The ascD sequence will appear in the EMBL/Genbank/DDBJ nucleotide sequence data libraries under accession number L25594.
RESULTS
Cloning and overexpression of the gene coding for the protocol I-purified E3. Purification of E3 by a previously reported procedure (protocol I) yielded amounts of protein sufficient only for preliminary mechanistic studies (15) . To facilitate further characterization of this enzyme, cloning and overexpression of the particular gene were pursued. Oligonucleotide (SFL2) screening of 4,000 plaques of YPT2 resulted in the isolation of 65 positive clones (1.63%), and analysis of 5 randomly selected positive plaques revealed identical restriction fragment patterns of the inserted DNA. Further Southern blotting of this DNA led to the isolation of a 3.2-kb KpnI fragment containing the gene coding for the putative E3, which was subsequently ligated into pUC18 (pSFL31) for exonuclease III digestion. Ligation of these deleted pSFL31 inserts into pUC19 followed by transformation and SDS-PAGE analysis revealed one particular construct, pYL36, which readily overexpressed the desired gene product. However, the expressed protein showed no E3 activity by either the GC-MS or NADH: DCPIP oxidoreductase assay. The negative results in the assay for E3 activity from the overexpressed E3 gene clone suggested that the protein isolated by protocol I may have been misidentified as E3.
Enzyme purification. Although E3 had been previously isolated by an unusual purification sequence (protocol I), the cloning results reported above strongly suggested that the resulting enzyme, which deceivingly appeared homogeneous at first, was still a mixture of two proteins in which E3 was only a minor component. To further purify the desired enzyme, chromatography on several affinity reagents that often bind to nicotinamide-utilizing enzymes, 2',5'-ADP-Sepharose (39) and NAD+-agarose (22) , was attempted, albeit with no success. Fortunately, it was found that the dye ligand blue A successfully bound and selectively eluted E3. Thus, a blue A column following phenyl-Sepharose was incorporated in the purification sequence. Such a modification rendered the tryptic digestion step unnecessary and, in effect, greatly simplified the purification procedure. As shown in Table 1 and Fig. 2 , purification by blue A affinity chromatography followed by gel filtration effected a 7,960-fold enrichment of E3, which is now truly homogeneous. In retrospect, a close examination by SDS-PAGE of the protein purified by the earlier protocol (15) occasionally revealed the presence of two protein bands differing by -1 to 2 kDa (Fig. 2, lane F) . This phenomenon was, however, inconsistent among preparations and was most often barely discernible. Chromatography on blue A apparently removed the major protein contaminant that was previously misidentified as E3.
Properties of E3. (i) Molecular weight. The molecular weight of the newly purified and homogeneous E3 was estimated by gel filtration to be 39,000. SDS-PAGE also showed a single band with a molecular weight of 39,000. Thus, the native enzyme is a monomeric protein consisting of a single polypeptide chain.
(ii) Isoelectric point. Purified E3 was subjected to electrophoresis on an analytical isoelectric focusing gel as described in Materials and Methods. The pl of E3 was determined to be 4.7 . (iii) UV-visible spectrum. The electronic spectrum of the newly purified E3 has significant adsorption above 300 nm, suggesting the existence of a flavin and possibly an iron-sulfur center.
(iv) Substrate specificity. The competence of NADPH as an alternate substrate for E3 was tested by replacing NADH with NADPH in the NADH:DCPIP oxidoreductase activity assay. The rate of the latter was less than 5% of that occurring when NADH was used under identical conditions, indicating that the E3 enzyme preferentially utilizes NADH as a substrate.
(v) Kinetic parameters for the NADH:DCPIP oxidoreductase activity. As an NADH:DCPIP oxidoreductase, E3 displayed normal Michaelis-Menten saturation kinetics. The Km of 37 ,uM for NADH and Vm. of 47 ,umol min 1 mg 1 for this catalysis were determined by plotting the data according to the method of Lineweaver and Burk.
(vi) Alternate electron acceptors. Enzyme E3 can utilize a variety of alternate electron acceptors for the oxidation of NADH. As shown in Table 2 , potassium ferricyanide, ferricytochrome c, and DCPIP were the most efficient electron acceptors tested. Interestingly, the quinones menadione and ubiquinone-0 are also good electron acceptors. Flavins, riboflavin, flavin mononucleotide, and flavin adenine dinucleotide are poor electron acceptors, suggesting that if E3 contains a flavin cofactor, it is tightly bound and virtually remains in the active site throughout the purification procedure.
Gene expression and protein purification of recombinant E3. A previously produced clone pYPT1 was found to contain the genuine E3 gene (ascD), as judged from its consistent hybridization with SFIA. The relative position of the E3 gene within the insert of pYPT1 was located by Southern blotting and DNA sequencing. The initiation codon of the ascD gene is only 270 bp away from the vector sequence of pYPT1, and the insert has an opposite orientation to the lac promoter of the vector. To match the orientation of the ascD gene to the direction of transcription of the lac promoter, the ascD gene was inverted by directionally subcloning the insert of pYPT1 into the BamHI-SacI sites of pUC19 (Fig. 3) . The resulting construct (pSFL28), after transformation into E. coli DH5a, readily expressed the desired gene product, as observed by SDS-PAGE. The recombinant E3 expressed in E. coli, under control of the lac promoter, is produced at levels nearly 30 times higher than those in Y pseudotuberculosis, as deduced from amounts of purified proteins. A summary of the five-step purification for the recombinant protein is presented in Table  3 . This simplified procedure typically yields > 10 mg of purified protein from 6 liters of cell culture of the E. coli DH5ac (pSFL28) system. Properties of the overexpressed E3. Characterization of the overexpressed E3 from E. coli revealed properties identical to those of the wild-type enzyme purified from Y pseudotuberculosis.
Nucleotide and amino acid sequences of E3. The nucleotide sequence of the E3 gene (ascD) and the deduced amino acid sequence of the corresponding protein are presented in Fig. 4 . The DNA sequence predicts a protein of 328 amino acids with a molecular weight of 36,160. This predicted molecular weight is in agreement with the molecular weight of 39,000 determined by SDS-PAGE and gel filtration. While translation is expected to start from ATG, the mature protein must have been posttranslationally modified, since a serine residue instead of a methionine was found as the N-terminal amino acid of the purified E3. Although expression of the protein is under the control of the lac promoter in E. coli (DH5cx), analysis of the ascD gene revealed a sequence, 5'-TAATAT-3', which resembles the E. coli consensus Pribnow box (5'-TATAAT-3') and is positioned 16 to 21 bp upstream from the translational start codon. A sequence resembling the -35 motif of consensus E. coli promoters (5'-TTGACA-3') could also be identified about 20 bp further upstream (5'-TTGAGT-3'). An 
DISCUSSION
Although E3 has been isolated by Gonzalez-Porque and Strominger from P. pseudotuberculosis (12) , its purification has always been complicated by the lack of a facile and sensitive assay to determine its activity. To circumvent this problem, we have developed a few convenient and sensitive methods to assay E3 activity. Among these, the particular method exploiting E3's capability to utilize DCPIP as electron acceptor for the oxidation of NADH affords the simplest means of assaying this enzyme's activity. Purification of E3 described herein relied upon the convenient NADH:DCPIP oxidoreductase assay. However, the catalytic role of the isolated enzyme was further analyzed by two additional methods which assay the sugar reductase activity by monitoring the product formation directly. While the TBA assay is very sensitive in detecting the E1-E3 product, it will also respond to 2-and 3-deoxyhexoses. Hence, a definitive verification involves conversion of the E1-E3 product (product 7) to the corresponding alditol acetates, which can be separated and identified by the GC-MS assay. Because product formation by incubation with purified E3 and El was confirmed by this assay, enzyme E3 purified on the basis of the NADH:DCPIP oxidoreductase activity was unequivocally demonstrated to be the desired sugar reductase.
As previously reported, initial E3 purification efforts in our group began with the procedure of Gonzalez-Porque and Strominger (12) , but this was soon modified to a procedure (protocol I) which led to a 3,600-fold overall purification of E3 (15) . While the protein purified by protocol I was valuable for preliminary mechanistic studies, characterization of possible cofactor(s) requires substantial amounts of homogeneous protein which was unattainable by the original protocol. Cloning of the gene coding for this protein was achieved by standard methodology. Although the nucleotide-derived gene product size (39,000 Da) closely matched that found for the putative E3 TTA AGT TTG TAT TGA GTA CGT CTA ATA AAC CTT ACA TAA TAT ATT TGG ACT TAT TTT ATG   TCA TTA AAT GTT AAG CTG CAT CCA TCA GGT ATT ATT TTT ACT TCC GAT GGA ACA TCT ingly resulted in the isolation of a new protein. This 8,000-foldpurified enzyme is a monomeric protein with a molecular weight of 39,000 and, most importantly, has a higher specific activity. It was suspected, therefore, that this newly purified enzyme was the genuine E3. To confirm this conclusion, the N-terminal amino acid sequence of the protein purified by protocol II was used to design an oligonucleotide primer (SFL4) which was used to screen and construct a clone that was found to be identical to a previously constructed clone, pYPT1, known to carry the entire genes for Ep and Eod. The fact that the gene coding for this newly purified protein is part of the ascarylose gene cluster provides convincing evidence that the enzyme purified by protocol II is the genuine E3. This conclusion was further supported by the fact that the catalytic properties of the ascD gene product purified from E. coli are identical to those of newly purified wild-type E3. Interestingly, high sequence homology (51%) was found between ascD and a previously unidentified gene (ORF 7.6) within the abequose biosynthetic cluster (rfb) of Salmonella typhimurium (20) .
Since compound 5 has been suggested as the common intermediate for the biosynthesis of most 3,6-dideoxyhexoses (except for colitose), identification of the gene function of ascD has therefore also allowed the assignment of ORF 7.6 in the Salmonella 0 antigen biosynthetic cluster as the corresponding E3 in the abequose biosynthetic pathway (40) .
As an NADH:DCPIP oxidoreductase, this newly purified enzyme exhibits a strong preference for NADH over NADPH, and its calculated Km and Vmax are substantially higher than those previously reported. In contrast to the protein purified by protocol I, the genuine E3 shows strong absorption above 300 nm, which is characteristic of a flavoprotein. Thus, the abovebaseline absorption at higher wavelength observed for the previously purified enzyme is not due to contaminants but rather is an intrinsic property of E3 and suggests the existence of a flavin and/or other cofactors. Apparently, earlier conceived notions on the mystery of E3 catalysis can now be attributed to the complexity of its purification arising mainly from a contaminant whose molecular weight and chromatographic behaviors are similar to those of the genuine E3. With the help of modern biochemical and genetic techniques, we have finally obtained the correct homogeneous enzyme, the purification of which had proved elusive for nearly two decades. Now that the pure enzyme is at hand, we can commence work on the mechanistic details of E3 catalysis.
